Bristol Myers Squibb Co. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. (BMY) slid 0.39% to $66.98 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.30% to 3,948.72 and the Dow Jones Industrial Average rising 0.23% to 32,105.25. This was the stock's second consecutive day of losses. Bristol Myers Squibb Co. closed $14.46 below its 52-week high ($81.44), which the company reached on December 1st.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) rose 0.05% to $151.13, Pfizer Inc. (PFE) rose 0.42% to $40.18, and Abbott Laboratories (ABT) rose 0.19% to $97.04. Trading volume (6.7 M) remained 1.6 million below its 50-day average volume of 8.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 23, 2023.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 23, 2023 16:42 ET (20:42 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.